Literature DB >> 17130627

Economics on trial: the use and abuse of economic methods in third party tobacco litigation.

Wendy Max1, Theo Tsoukalas.   

Abstract

OBJECTIVE: To analyse how the tobacco industry responded to economic models and methods used in third party payer tobacco litigation that has occurred since 1994.
METHODS: Identified 12 third party payer cases and reviewed the transcripts using WinMax qualitative software. Focused on defendant's opening and closing statements, followed by trial testimony, depositions, and plaintiff's transcripts.
RESULTS: Tobacco industry defendants tried to create doubt and confusion about whether or not smoking caused disease and by extension led to health care costs; argued that the economic models used were not legitimate and were not appropriate for estimating the costs incurred by plaintiffs; and criticised the data sources used because they did not consist of the individuals whose health care costs were being sought.
CONCLUSIONS: Faced with a new and unprecedented wave of anti-tobacco litigation from third party payers, the tobacco industry tried to adapt strategies that had been used successfully in the past-creation of unfounded doubt and confusion, and manipulation of the discovery process to force plaintiffs to withdraw or concede defeat. The strategies failed because credible economic models of the health care costs of smoking had been developed that were able to quantify the damages to a large group of health care recipients, because plaintiff's attorneys were able to commit significant resources and willing to undertake substantial financial risk to defend their new legal approaches, and because previous arguments related to individual responsibility were deemed irrelevant in third party litigation.

Entities:  

Mesh:

Year:  2006        PMID: 17130627      PMCID: PMC2563584          DOI: 10.1136/tc.2004.009555

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  11 in total

Review 1.  Medical costs of smoking in the United States: estimates, their validity, and their implications.

Authors:  K E Warner; T A Hodgson; C E Carroll
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Smoking-attributable medical care costs in the USA.

Authors:  V P Miller; C Ernst; F Collin
Journal:  Soc Sci Med       Date:  1999-02       Impact factor: 4.634

3.  Evaluating the tobacco settlement damage awards: too much or not enough?

Authors:  Maribeth Coller; Glenn W Harrison; Melayne Morgan McInnes
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

4.  State estimates of Medicaid expenditures attributable to cigarette smoking, fiscal year 1993.

Authors:  L S Miller; X Zhang; T Novotny; D P Rice; W Max
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

5.  A new attack on smoking using an old-time remedy.

Authors:  M C Moore; C J Mikhail
Journal:  Public Health Rep       Date:  1996 May-Jun       Impact factor: 2.792

6.  Risk of automobile accidents in cigarette smokers.

Authors:  R J Brison
Journal:  Can J Public Health       Date:  1990 Mar-Apr

7.  Medical-care expenditures attributable to cigarette smoking--United States, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1994-07-08       Impact factor: 17.586

8.  Injury death excesses in smokers: a 1990-95 United States national cohort study.

Authors:  B N Leistikow; D C Martin; S J Samuels
Journal:  Inj Prev       Date:  2000-12       Impact factor: 2.399

Review 9.  The Tobacco Deposition and Trial Testimony Archive (DATTA) project: origins, aims, and methods.

Authors:  Ronald M Davis; Clifford E Douglas; John K Beasley
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

10.  Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.

Authors:  Clifford E Douglas; Ronald M Davis; John K Beasley
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

View more
  1 in total

1.  Perspectives on econometric modelling to inform policy: a UK qualitative case study of minimum unit pricing of alcohol.

Authors:  Srinivasa V Katikireddi; Lyndal Bond; Shona Hilton
Journal:  Eur J Public Health       Date:  2013-12-23       Impact factor: 3.367

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.